HBF is pleased to connect our blog readers to Christine Kukka’s monthly HBV Journal Review that she writes for the HBV Advocate. The journal presents the
latest in hepatitis B research, treatment, and prevention from recent academic and medical journals. This month, the following topics are explored:
- Half of Patients with HBV Genotype C Will Lose HBsAg
- Five-year Study Shows Tenofovir Dramatically Improves Cirrhosis
- Tenofovir Also Effective Against Adefovir and Multi-drug Resistance
- Tenofovir Is Effective in Pregnant Women Who Have Resistance to Other Drugs
- Estimates of Liver Cirrhosis in the U.S. Jump 50%
- Taking Antivirals for Three Years After Undetectable Viral Load Reduces Relapse Risk
- Study Finds Antivirals Can Replace Costly HBIG after Liver Transplant Surgery
- Hospitalized Hepatitis B Patients Have Higher Death Rates and Longer Stays Than Hepatitis C Patients
- Small Study Finds Psoriasis Treatment May Not Reactivate Hepatitis B
- Emulsion Made from Ginkgo Leaves Shows Promise Against Hepatitis B
- Experimental Treatment Boosts the Immune System and Slows Viral Replication
- HIV-HBV Coinfected Patients Have High Rates of Hip Fractures
Continue reading "HBV Journal Review April 2015"